Export 36 results:
Author Title [ Type(Asc)] Year
Filters: Author is VanVeldhuisen, Paul C  [Clear All Filters]
Journal Article
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., Awh, C. C., Kunimoto, D. Y., Marcus, D. M., Wroblewski, J. J., and King, J., Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial., JAMA, vol. 317, no. 20, pp. 2072-2087, 2017.
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., Altaweel, M., and Berinstein, D. M., Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial., JAMA Ophthalmol, vol. 136, no. 4, pp. 337-345, 2018.
H. J. Landy, S Laughon, K., Bailit, J. L., Kominiarek, M. A., Gonzalez-Quintero, V. Hugo, Ramirez, M., Haberman, S., Hibbard, J., Wilkins, I., D Branch, W., Burkman, R. T., Gregory, K., Hoffman, M. K., Learman, L. A., Hatjis, C., VanVeldhuisen, P. C., Reddy, U. M., Troendle, J., Sun, L., and Zhang, J., Characteristics associated with severe perineal and cervical lacerations during vaginal delivery., Obstet Gynecol, vol. 117, no. 3, pp. 627-35, 2011.
I. U. Scott, VanVeldhuisen, P. C., Oden, N. L., Ip, M. S., Blodi, B. A., Hartnett, M. Elizabeth, and Cohen, G., Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10., Ophthalmology, vol. 118, no. 2, pp. 345-52, 2011.
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., King, J., Antoszyk, A. N., Peters, M. A., and Tolentino, M., Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4., JAMA Ophthalmol, vol. 135, no. 6, pp. 639-649, 2017.
R. N. Khurana, Oden, N. L., VanVeldhuisen, P. C., Scott, I. U., Blodi, B. A., and Ip, M. S., Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents : SCORE2 report 12: secondary analysis of the SCORE2 clinical trial., Graefes Arch Clin Exp Ophthalmol, vol. 239, no. 7, pp. 1839-1851, 2021.
J. Kim, Dally, L. G., Ederer, F., Gaasterland, D. E., VanVeldhuisen, P. C., Blackwell, B., E Sullivan, K., Prum, B., Shafranov, G., Beck, A., and Spaeth, G. L., The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations., Ophthalmology, vol. 111, no. 11, pp. 2109-16, 2004.
F. Ederer, Gaasterland, D. A., Dally, L. G., Kim, J., VanVeldhuisen, P. C., Blackwell, B., Prum, B., Shafranov, G., Allen, R. C., and Beck, A., The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results., Ophthalmology, vol. 111, no. 4, pp. 651-64, 2004.